Athira Pharma, Inc. (ATHA) Earnings
|
Expand Research on ATHA
| Next EPS Date | N/A | EPS Growth Rate | -124.0% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | -305.5% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +2.9% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
11/6/25  |
Q325 | N/A | -$0.13 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 11/6/25 | Q325 | -$1.68 | -$0.13 | -$1.55 | N/A | N/A | N/A |  | | Details | |
| 8/18/25 |
Q225 | N/A | -$0.22 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 5/9/25 |
Q125 | -$0.23 | -$0.18 | -$0.05 | N/A | N/A | N/A | | | Details | |
| 3/20/25 |
Q424 | N/A | -$0.46 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 11/8/24 |
Q324 | -$0.75 | -$0.70 | -$0.05 | N/A | N/A | N/A | | | Details | |
| 8/12/24 | Q224 | N/A | -$0.74 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/1/24 | Q224 | -$0.70 | -$0.74 | +$0.04 | N/A | N/A | N/A | | | Details |
